Cardiopulmonary Stress Testing Systems Market is Expanding at a CAGR of 4.6% by 2025

Regarding the vendor landscape, the global cardiopulmonary stress testing systems market boasts the presence of large companies such as Koninklijke Philips N.V., Hill-rom Holdings Inc., General Electric Company, MGC Diagnostics Corporation, OSI Systems Inc., Masimo, NIHON KOHDEN CORPORATION, COSMED, Halma plc, Schiller AG, and Vyaire Medical Inc. among others. This renders a high degree of competition amongst these companies. In this scenario, players have been heavily relying on developing technologically advanced devices to stay strong in this market. The emergence of emerging market players at an exponential rate to develop ancillary devices needed for cardiopulmonary stress testing is a notable trend observed in this market.

Further, key players in the cardiopulmonary stress testing systems market are considering collaborations and licensing agreements to penetrate relatively untapped markets that have low entry barriers along with high growth potential. As a result, these players are expected to get more and more involved into mergers and acquisitions and strategic partnerships with regional players over the forthcoming years.

Read Report Overview: https://www.transparencymarketresearch.com/cardiopulmonary-stress-testing-systems-market.html

Considering the development of diverse technological products for cardiopulmonary stress testing and various other factors, a report by Transparency Market Research (TMR) states the global cardiopulmonary stress testing systems market stood at US$2.08 bn in 2016. Expanding at a CAGR of 4.6% for the forecast period between 2017 and 2025, the market is expected to be valued at US$3.08 bn by the end of 2025.

Among the various product types, the segment of cardiopulmonary exercise testing system is anticipated to lead the global cardiopulmonary stress testing systems market over the forecast period. By end-user, hospitals segment is likely to dominate the market in terms of value over the forecast period of 2017-2025. Geography-wise, North America is anticipated to continue its dominance in the global cardiopulmonary stress testing systems market vis-à-vis revenue over the forecast period.

Request Sample of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1530

Increasing Adoption of Stress Testing Procedures to Assess Heart Functioning a Boon for Market

The global cardiopulmonary stress testing systems market is driven by several crucial factors. Diagnosis of proper functioning of the heart remains the first line of treatment that helps physicians to assess the health status of patients who are at risk of cardiovascular diseases. A stress test helps physicians to evaluate the heart functioning based on several parameters such as blood pressure, heart rhythm, breathing, etc. and is performed typically on treadmill or cycle. For instance, stress echocardiography involves capturing ultrasound images of heart when the heart reaches peak level, which gives insights about the supply of blood and oxygen from the heart while performing an exercise. Alternately, an imaging test is conducted if the patient is unable to walk on the treadmill or cycle or if the exercise stress test does not give satisfactory results to diagnose the cause of heart problem.

Buy Cardiopulmonary Stress Testing Systems Market Research Report: https://www.transparencymarketresearch.com/checkout.php?rep_id=1530&ltype=S

Continual Development of Technologically Advanced Products with Add-on Features Boosts Growth

Apart from this, the consistent development of technologically advanced cardiopulmonary stress testing systems is also a significant factor acting in favor of the growth of cardiopulmonary stress testing systems market. This is mainly because stress testing procedures are increasingly being adopted for early diagnosis of heart diseases so as to minimize the risk of emergency situations that may prove to be fatal.

Global Cardiopulmonary Stress Testing Systems Market Driven by Increasing Prevalence of Coronary Artery Disease

Over the past few years, cardiopulmonary exercise testing (CPET) has been recognized as a vital clinical tool, used to assess exercise capacity in patients and predict various cardiac conditions. CPET provides the assessment of integrative exercise response including cardiovascular, pulmonary, and skeletal muscle systems. Since the developments in the technology, cardiopulmonary stress testing systems are being consistently used in many clinical applications.

Changes in the lifestyle, stressful life, and lack of exercise have led to the growing obese population. This has led to the growth of cardiac patients, which has, in turn, increased the acceptance of cardiopulmonary stress testing systems. Transparency Market Research (TMR), in its new report, states that the global cardiopulmonary stress testing systems market was valued at US$3.30 bn in 2014 and is predicted to reach US$6.67 bn by 2023, expected to progress at an 8.20% CAGR from 2015 to 2023.

TMR experts answer a few important questions based on the global cardiopulmonary stress testing systems, which the readers would like to know:

Q. How is obesity the most important driving factor for the global cardiopulmonary stress testing systems market?

The modern lifestyle and the increasing habit of eating junk food have led to significant growth of obese people. The increasing cases of obesity have led to the increase in cardiac disorders. Currently, North America records the highest number of obese people. However, the number of obese people is expected to increase in Asia Pacific in the years to come. The global rise in the obese people is expected to be the most important factor driving the global cardiopulmonary stress testing systems market.

Q. Will technology plan an important role in the development of the global market?

Yes, technology has helped towards the development of many industries, and the global cardiopulmonary stress testing systems market is not an exception. Technological advancements in cardiopulmonary stress testing systems have enhanced the functional parameters, which is likely to propel the global market. Key companies operating in the global cardiopulmonary stress testing systems market are aiming to adopt new technologies for the development of new systems.

Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1530

Q. How will the global market be affected by the rising occurrence of cardiovascular diseases?

The occurrence of cardiovascular diseases is been increasing since the recent past, which has been one of the driving factors for the global market. As per the World Health Organization, the coronary artery disease accounts for 64% of the total global deaths occurring from cardiovascular conditions. This has thus been recognized as one of the primary causes of average quality of life for a majority of the global population.

It is always boosting to see researchers investing more towards the development of new products. Recently, a women’s special hospital in Boston showed interest in developing new cardiopulmonary stress testing systems.

With many leading players showing interest and efforts towards the development of new cardiopulmonary stress testing systems, the global market is expected to show promising growth opportunities across many regions. The presence of key equipment manufacturers of cardiopulmonary stress testing systems, the application of laws including the Affordable healthcare Act, and the high awareness among people are some of the factors expected to propel the global cardiopulmonary stress testing systems market in the near future.

Global Report on Cardiopulmonary Stress Testing Systems Market - An Overview of Growth Factors

The global cardiopulmonary stress testing systems market will exhibit a notable CAGR of 8.20% during the forecast period from 2015 to 2023, says Transparency Market Research (TMR). In 2014, the global cardiopulmonary stress testing systems market was worth US$3.3 bn and by 2023, the market is projected to double in value and be worth US$6.6 bn. The dynamics of the global cardiopulmonary stress testing systems market are shaped by several drivers and restraints. Here are the top 5 trends that will impact the global cardiopulmonary stress testing systems market in the foreseeable future.

Browse Full Report: http://www.transparencymarketresearch.com/cardiopulmonary-stress-testing-systems.html

5 Key Trends Shaping the Global Cardiopulmonary Stress Testing Systems Market

• Increasing Prevalence of Coronary Artery Disease: Coronary artery disease (CAD) is considered the most common type of heart disease and is a leading cause of death in the U.S. in both women and men. The prevalence of CAD is rising globally, which will drive the global cardiopulmonary stress testing systems market significantly in the coming few years. According to the WHO, around 17.5 mn people died from cardiovascular diseases in 2012, amounting to 31% of global deaths and out of these 7.4 mn were caused by coronary heart disease.

• Rising Obesity Rate: According to the CDC, over one-third of adults in the U.S. are obese. Heart disease is one of the major obesity-related conditions. The growing rate of obesity in the world is projected to drive the global cardiopulmonary stress testing systems market substantially in the coming few years.

• New Technologies: The global cardiopulmonary stress testing systems market will benefit from advancements in technology. The penetration of new monitoring technologies in the market is greatly improving the diagnosis rate.

• Implementation of Legal Provisions: Although the global cardiopulmonary stress testing systems market will expand significantly during the forecast period, it will be suppressed by the implementation of legal provisions such as the Affordable Care Act, promoting cost cutting strategies. The global cardiopulmonary stress testing systems market will also be restrained by the slow growth in the number of SPECT MPI procedures.

• Opportunities in Emerging Nations: Players in the global cardiopulmonary stress testing systems market will benefit from the huge growth potential on offer in emerging markets around the world. China and India are two of the most promising markets for cardiopulmonary stress testing systems. The cardiopulmonary stress testing systems market in the APAC region is projected to progress at the highest CAGR during the forecast period. In addition to this, Brazil and Mexico in the Latin America cardiopulmonary stress testing systems market will witness strong growth in the aforementioned forecast period.

Brochure Download: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1530

Some of the players operating in multiple avenues in the global cardiopulmonary stress testing systems market are CareFusion Corporation, Philips Healthcare, Spacelabs Healthcare, and GE Healthcare. Other notable players operating in the global cardiopulmonary stress testing systems market are COSMED, Nihon Kohden Corporation, MGC Diagnostic Corporation, SunTech Medical, and Schiller.

Future Trends in Cardiopulmonary Stress Testing Systems Market

A new Transparency Market Research report states that the global cardiopulmonary stress testing system market stood at US$3.3 bn in 2014 and is predicted to reach US$6.6 bn by 2023. It is expected to expand at a CAGR of 8.20% from 2015 to 2023. The title of the report is “Cardiopulmonary Stress Testing Systems Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023”.

Browse the full Cardiopulmonary Stress Testing Systems Market (Cardiopulmonary Exercise Testing Systems, Stress ECG, Pulse Oximeters, Stress Blood Pressure Monitors, and SPECT) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023 report at http://www.transparencymarketresearch.com/cardiopulmonary-stress-testing-systems.html

As per the report, the rising occurrence of coronary artery diseases such as myocardial infarction and angina pectoris will fuel the market for cardiopulmonary stress testing systems. The increasing aging population and increasing rate of obesity will further augment the market. In addition, the growth in the count of hospitals will also raise the demand for cardiopulmonary stress testing systems in the coming years. Furthermore, the rising number of new monitoring technologies has improved the rate and accuracy of diagnosis of cardiopulmonary diseases, thus boosting the overall market. On the other hand, factors including legal provisions such as the Affordable Care Act, which raises cost-cutting/containment strategies, and the sluggish growth in the count of SPECT MPI procedures may restrain the growth of the market in forthcoming years.

On the basis of product type, the market is segmented into cardiopulmonary exercise testing (CPET) systems, pulse oximeters, stress blood pressure monitors, stress ECG, and single-photon emission computed tomography (SPECT). Amongst these, cardiopulmonary exercise testing systems are further segmented into desktop CPET systems and portable CPET systems. The segment of CPET systems emerged as the largest segment of the global cardiopulmonary stress testing systems market. This is owing to the increasing occurrence of cardiac diseases, technical advancements, and the swift growth in the aging population. In addition, the rising disposable income of consumers, growing lifestyle disorders, and increasing incidence of coronary artery diseases are poised to augment the growth of the market in the forecast horizon.

Request A Sample Of This Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1530

On the basis of geography, the market is segmented into Europe, North America, Latin America, the Middle East and North Africa, Rest of Europe, and Rest of the World (RoW). Amongst these, North America led the global cardiopulmonary stress testing systems market in 2014 on the basis of revenue, trailed by Europe. These two regions are poised to maintain their dominance all through the forecast horizon. The reason for the dominance of these regions is the presence of a number of cardiopulmonary patients and existence of a huge number of hospitals that have been rapidly adopting cutting-edge products. On the other hand, Asia Pacific is predicted to rise at the highest CAGR in the forecast horizon. In Asia Pacific, India and China are the leading markets presenting lucrative opportunities for manufacturers of cardiopulmonary stress testing systems

According to the report, the key players operating in the market include CareFusion Corporation, COSMED, GE Healthcare, MGC Diagnostics Corporation, Nihon Kohden Corporation, Philips Healthcare, Schiller AG, Spacelabs Healthcare, SunTech Medical, Inc., and Welch Allyn, Inc.